J. Goldman & CO LP Exact Sciences Corp Transaction History
J. Goldman & CO LP
- $3.8 Billion
- Q1 2025
A detailed history of J. Goldman & CO LP transactions in Exact Sciences Corp stock. As of the latest transaction made, J. Goldman & CO LP holds 20,000 shares of EXAS stock, worth $960,800. This represents 0.05% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$960,800% of portfolio
0.05%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding EXAS
# of Institutions
636Shares Held
157MCall Options Held
1.64MPut Options Held
1.5M-
Capital World Investors Los Angeles, CA17.8MShares$857 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$847 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$601 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$580 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$318 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.5B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...